Lilly Acquires Verve for $1.3 Billion to Boost Cardiac Care with Gene Editing Sufiyan Khan Jun 17, 2025 Lilly Acquires Verve: A $1.3 Billion Leap Toward One-Time Heart Disease Treatment In a groundbreaking...